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Background: It is unclear whether functional outcomes improve or deteriorate with age following
surgery for Hirschsprung’s disease. The aim of this cross-sectional study was to determine the long-term
functional outcomes and quality of life (QoL) in patients with Hirschsprung’s disease.
Methods: Patients with pathologically proven Hirschsprung’s disease older than 7 years were included.
Patients with a permanent stoma or intellectual disability were excluded. Functional outcomes were
assessed according to the Rome IV criteria using the Defaecation and Faecal Continence questionnaire.
QoL was assessed by means of the Child Health Questionnaire Child Form 87 or World Health
Organization Quality of Life questionnaire 100. Reference data from healthy controls were available
for comparison.
Results: Of 619 patients invited, 346 (55⋅9 per cent) responded, with a median age of 18 (range 8–45)
years. The prevalence of constipation was comparable in paediatric and adult patients (both 22⋅0 per cent),
and in patients and controls. Compared with controls, adults with Hirschsprung’s disease significantly
more often experienced straining (50⋅3 versus 36⋅1 per cent; P=0⋅011) and incomplete evacuation (47⋅4
versus 27⋅2 per cent; P<0⋅001). The prevalence of faecal incontinence, most commonly soiling, was lower
in adults than children with Hirschsprung’s disease (16⋅8 versus 37⋅6 per cent; P< 0⋅001), but remained
higher than in controls (16⋅8 versus 6⋅1 per cent; P= 0⋅003). Patients with poor functional outcomes scored
significantly lower in several QoL domains.
Conclusion: This study has shown that functional outcomes are better in adults than children, but
symptoms of constipation and soiling persist in a substantial group of adults with Hirschsprung’s disease.
The persistence of defaecation problems is an indication that continuous care is necessary in this specific
group of patients.
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Introduction
Hirschsprung’s disease (HD) is a congenital absence of gan-
glion cells of the distal bowel that inmost instances presents
with severe functional obstruction shortly after birth. Fol-
lowing diagnosis, resection is usually performed to remove
the aganglionic bowel and to restore continuity. Although
many patients may attain normal bowel function following
surgery, defaecation disorders, such as constipation or
faecal incontinence, can persist1–11.
It has been postulated that functional outcomes
improve as patients grow older, especially after reach-
ing adolescence5–7. Other studies, however, have drawn
attention to the fact that long-term outcomes of HD in
adulthood are far from satisfactory2–4. Indeed, one study3
found that defaecation problems actually deteriorated
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after the patients reached adulthood. Unfortunately, a lack
of data on healthy controls hinders interpretation of the
majority of these studies.
Persistent defaecation disorders, such as constipation
and faecal incontinence, can potentially have a negative
influence on quality of life (QoL)12,13. A distinction is
often made between generic QoL and health-related QoL,
the latter focusing primarily on aspects of life that are
influenced directly by an individual’s health. In patients
with HD, the relationship between functional complaints
and QoL has been studied previously, but these studies
were often performed with health-related QoL question-
naires and only rarely were generic QoL questionnaires
used14. Moreover, it remains unclear how functional out-
comes continue to influence QoL after the transition into
adulthood14.
The primary aim of this study was to investigate the
long-term functional outcomes in different age groups and
to compare them with data from matched controls. Sec-
ondary aims were to identify factors associated with poor
outcomes and to evaluate the influence of poor functional
outcomes on QoL using generic QoL questionnaires.
Methods
This study had the approval code METc 2013/226 and was
performed in compliance with the requirements of the local
medical ethics review board.Written informed consent was
obtained from each participant.
Themedical records of all known patients diagnosed with
HD in all six paediatric surgical centres in the Nether-
lands were reviewed. Inclusion criteria were pathologically
proven HD and a minimum age of 8 years. The following
variables were collected from the records: co-morbidities,
length of aganglionosis, surgical treatment, episodes of
enterocolitis, surgical complications and additional surgical
interventions. Enterocolitis was defined as the presence of
symptoms such as abdominal distension, diarrhoea, bloody
stools and/or fever with the intention to treat as such15.
Surgical complications were defined as complications that
occurred within 30 days and were the direct result of the
initial surgical intervention (such as anastomotic leakage,
wound infection and adhesions).
After the exclusion of patients who were ineligible to par-
ticipate (deceased, living abroad, had a permanent stoma
or an intellectual disability), the remaining patients were
invited to participate in the study. In the case of chil-
dren aged between 8 and 17 years, parents or caregivers
were asked to participate together with the patients, or on
their behalf. On agreeing to participate, patients received
questionnaires on anorectal functioning and QoL. For
children, these were the Paediatric Defaecation and Fae-
cal Continence (P-DeFeC) questionnaire16 and the Child
Health Questionnaire Child Form 87 (CHQ-CF87)17.
Adults received the Defaecation and Faecal Continence
(DeFeC) questionnaire16 and the WHO Quality of Life
100 (WHOQOL-100) questionnaire18.
Assessment of functional outcomes
Functional outcomes were assessed using patients’ answers
to the P-DeFeC andDeFeC questionnaires, which allowed
the authors to score the Rome IV criteria, and assess the use
of therapies for constipation and faecal incontinence.
Constipation was defined by the Rome IV criteria for
functional constipation19. To meet these criteria, patients
should have at least two of the following symptoms: strain-
ing, hard or lumpy stools, incomplete evacuation, anorectal
obstruction, use of manual manoeuvres to facilitate defae-
cation, or fewer than three bowel movements a week. Add-
itionally, loose stools should rarely be present without the
use of laxatives. The individual symptoms incorporated in
the Rome IV criteria were also assessed for functional con-
stipation, which had to occur at least several times a month.
Faecal incontinence was defined by the Rome IV criteria
for faecal incontinence as recurrent uncontrolled passage
of faecal material, including soiling, at least several times a
month20. Several subtypes of faecal incontinence were also
assessed, such as soiling (loss of small amounts of faeces),
urge incontinence (inability to reach the toilet in time),
incontinence to solid stool (loss of large amounts of solid
faeces without having felt urge) and incontinence to liquid
stool (loss of watery stools or diarrhoea).
By means of the questionnaire, an evaluation was under-
taken of the use of laxatives and bowel management at least
several times a month as therapy for constipation or faecal
incontinence.
Reference data for the P-DeFeC and DeFeC question-
naires were available from studies that had been performed
previously in the general Dutch population. This produced
1103 healthy children and adults who did not have a history
of bowel surgery or somatic diseases that could influence
their bowels21,22.
Assessment of quality of life
TheCHQ-CF8717 was used to assessQoL in children aged
8–17 years. This is a generic QoL questionnaire with 87
items that are scored on a four- to six-point Likert scale.
Following completion, ten multi-item domains and two
single-item questions were calculated and converted to a
0–100-point continuum, where a higher score indicates
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Table 1 Patient characteristics and dropout analysis
Non-responders (n=273) Responders (n=346) P†
Age (years)* 22 (8–50) 18 (8–45) 0⋅004‡
Sex ratio (M : F) 224 : 49 274 : 72 0⋅373
Co-morbidities 26 (9⋅5) 33 (9⋅5) 1⋅000
Length of aganglionosis 0⋅804
Ultrashort 5 (1⋅8) 10 (2⋅9)
Rectosigmoid 222 (81⋅3) 282 (81⋅5)
Long segment 23 (8⋅4) 29 (8⋅4)
Total colonic 23 (8⋅4) 25 (7⋅2)
Preoperative enterocolitis 30 (11⋅0) 46 (13⋅3) 0⋅395
Primary surgical treatment 0⋅443
Surgical reconstruction 265 (97⋅1) 337 (97⋅4)
Sphincterectomy 3 (1⋅1) 4 (1⋅2)
Other 2 (0⋅7) 0 (0⋅0)
None/conservative 3 (1⋅1) 5 (1⋅4)
Surgical reconstruction 0⋅166
Duhamel 149 (56⋅2) 210 (62⋅3)
Soave 1 (0⋅4) 1 (0⋅3)
Rehbein 80 (30⋅2) 73 (21⋅7)
Swenson 0 (0) 1 (0⋅3)
Transanal endorectal pull-through 35 (13⋅2) 52 (15⋅4)
Postoperative complication 26 of 270 (9⋅6) 36 of 341 (10⋅6) 0⋅706
Postoperative enterocolitis 24 of 270 (8⋅9) 47 of 341 (13⋅8) 0⋅061
Redo pull-through 15 of 270 (5⋅6) 23 of 341 (6⋅7) 0⋅546
Values in parentheses are percentages unless indicated otherwise; *values are median (range). †χ2 test, except ‡Mann–Whitney U test.
better QoL. The following domains were assessed for this
study: behaviour, mental health, self-esteem and general
health.
TheWHOQOL-10018 was used to assess QoL in adults.
The WHOQOL-100 consists of 100 items covering six
domains and a general evaluative facet (overall QoL and
general health). The items are scored on a five-point Likert
scale. Calculated domain scores range between 4 and 20
points; a higher domain score indicates better QoL. The
following domains were analysed in the present study:
overall QoL, physical health, psychological health and
social relationships.
Reference data for the healthy Dutch population were
available for both the CHQ-CF8723 and WHOQOL-100
questionnaires (courtesy of J. de Vries, University of
Tilburg)24.
Statistical analysis
Proportions are reported as prevalence percentages with
95 per cent confidence intervals. Quantitative variables are
expressed as mean(s.d.) or median (range). Statistical tests
used were χ2, Mann–Whitney U and t tests. Univariable
and multivariable logistic regression analyses were used to
test the association between potential risk factors and the
likelihood of faecal incontinence, with results reported as
odds ratios (ORs) with 95 per cent confidence intervals.
The multivariable analysis was built using variables that
tended towards significance (P< 0⋅100) in the univariable
analyses. Two-sided P< 0⋅050 was considered statistically
significant. Data were analysed with SPSS® version 23.0
for Windows® (IBM, Armonk, New York, USA).
Results
Based on the inclusion criteria, 830 patients were identified
as eligible for the study, of whom 211 were subsequently
excluded: patients who had died (43), who lived abroad (47),
whose addresses were not available (10) or whowere unable
to complete one of the questionnaires because of a perm-
anent stoma (25) or intellectual disability (such as Down
syndrome, 86). The most common reasons for a perma-
nent stomawere postoperative complications (7), persistent
constipation (5) and severe intellectual disability (3). A total
of 619 patients received an invitation to participate in the
study (Fig. S1, supporting information).
Following invitation, 346 patients and their parents
or caregivers (55⋅9 per cent) agreed to participate and
completed the questionnaires (Table 1). There were 173
children aged 8–17 years and 173 adults with HD.
Additional patient characteristics are shown in Table 1.
A dropout analysis showed that the only significant dif-
ference between non-responders and responders was in
median age: 22 (range 8–50) versus 18 (8–45) years respec-
tively (P= 0⋅004). The 346 patients who responded were
randomly matched 1 : 1 with controls on the basis of sex
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Table 2 Functional outcomes in children and adults
Children (8–17 years) Adults (≥ 18 years)
Patients
(n=173)
Controls
(n=147) P†
Patients
(n=173)
Controls
(n=147) P†
P (patients:
children versus adults)†
Constipation
Prevalence (Rome IV) 38 (22⋅0) 21 (14⋅3) 0⋅077 38 (22⋅0) 28 (19⋅0) 0⋅520 1⋅000
Symptoms
Straining 64 (37⋅0) 32 (21⋅8) 0⋅003 87 (50⋅3) 53 (36⋅1) 0⋅011 0⋅013
Lumpy or hard stools 5 (2⋅9) 14 (9⋅5) 0⋅012 11 (6⋅4) 9 (6⋅1) 0⋅931 0⋅125
Incomplete evacuation 68 (39⋅3) 13 (8⋅8) <0⋅001 82 (47⋅4) 40 (27⋅2) <0⋅001 0⋅129
Anorectal obstruction 39 (22⋅5) 17 (11⋅6) 0⋅010 44 (25⋅4) 25 (17⋅0) 0⋅068 0⋅529
Manual manoeuvres 0 (0) 3 (2⋅0) 0⋅059 10 (5⋅8) 7 (4⋅8) 0⋅686 0⋅001
< 3 bowel movements per week 12 (6⋅9) 12 (8⋅2) 0⋅678 18 (10⋅4) 19 (12⋅9) 0⋅482 0⋅252
Laxative use 53 (30⋅6) 6 (4⋅1) <0⋅001 9 (5⋅2) 6 (4⋅1) 0⋅636 <0⋅001
Bowel management for constipation 31 (17⋅9) 1 (0⋅7) <0⋅001 14 (8⋅1) 1 (0⋅7) 0⋅002 0⋅007
Faecal incontinence
Prevalence (Rome IV) 65 (37⋅6) 9 (6⋅1) <0⋅001 29 (16⋅8) 9 (6⋅1) 0⋅003 <0⋅001
Subtypes*
Soiling 60 (34⋅7) 6 (4⋅1) <0⋅001 29 (16⋅8) 6 (4⋅1) <0⋅001 <0⋅001
Urge incontinence 7 (4⋅0) 2 (1⋅4) 0⋅148 2 (1⋅2) 3 (2⋅0) 0⋅525 0⋅091
Incontinence to solid stool 12 (6⋅9) 3 (2⋅0) 0⋅039 2 (1⋅2) 3 (2⋅0) 0⋅525 0⋅006
Incontinence to liquid stool 15 (8⋅7) 2 (1⋅4) 0⋅004 5 (2⋅9) 5 (3⋅4) 0⋅793 0⋅021
Bowel management for faecal incontinence 19 (11⋅0) 1 (0⋅7) <0⋅001 3 (1⋅7) 0 (0⋅0) 0⋅109 0⋅017
Values in parentheses are percentages. *Respondents often had various types of faecal incontinence. †χ2 test.
Table 3 Prevalence and likelihood of faecal incontinence
Likelihood of faecal incontinence‡
Univariable analysis Multivariable analysis
Total no.
of patients*
Prevalence of
faecal
incontinence (%) P† Odds ratio P Odds ratio P
Overall 346 27⋅2 (22⋅5, 31⋅9)
Sex 0⋅175
Men 274 (79⋅2) 28⋅8 (23⋅4, 34⋅2) 1⋅00 (reference)
Women 72 (20⋅8) 21 (11, 30) 0⋅65 (0⋅35, 1⋅21) 0⋅177
Patient group <0⋅001
Children (8–17 years) 173 (50⋅0) 37⋅6 (30⋅3, 44⋅9) 1⋅00 (reference) 1⋅00 (reference)
Adults (≥18 years) 173 (50⋅0) 16⋅8 (11⋅1, 22⋅4) 0⋅33 (0⋅20, 0⋅55) <0⋅001 0⋅35 (0⋅21, 0⋅58) < 0⋅001
Length of aganglionosis 0⋅482
Ultrashort 10 (2⋅9) 20 (–10, 50) 0⋅70 (0⋅15, 3⋅38) 0⋅660
Rectosigmoid 282 (81⋅5) 26⋅2 (21⋅1, 31⋅4) 1⋅00 (reference)
Long segment 29 (8⋅4) 28 (10, 45) 1⋅07 (0⋅45, 2⋅52) 0⋅876
Total colonic 25 (7⋅2) 40 (19, 61) 1⋅87 (0⋅81, 4⋅35) 0⋅144
Postoperative complication 0⋅777
No 305 (89⋅4) 27⋅2 (22⋅2, 32⋅2) 1⋅00 (reference)
Yes 36 (10⋅6) 25 (10, 40) 0⋅89 (0⋅40, 1⋅97) 0⋅769
Redo pull-through 0⋅001
No 323 (93⋅4) 25⋅1 (20⋅3, 29⋅8) 1⋅00 (reference) 1⋅00 (reference)
Yes 23 (6⋅6) 57 (35, 78) 3⋅88 (1⋅64, 9⋅20) 0⋅002 3⋅54 (1⋅46, 8⋅62) 0⋅005
Values in parentheses are 95 per cent confidence intervals unless indicated otherwise; *values in parentheses are percentages. †χ2 test. ‡Logistic regression
analysis; variables with P< 0⋅100 in univariable analysis were subsequently included in the multivariable analysis.
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Fig. 1 Quality-of-life scores of children and adults with
Hirschsprung’s disease compared with reference data from
healthy controls. a Child Health Questionnaire Child Form
(CHQ-CF87) scores in children; bWHO Quality of Life
(WHOQOL-100) score in adults. Values are mean with 95 per
cent confidence interval. QoL, quality of life. *P< 0⋅050,
†P< 0⋅001 (t test)
and age. Because of the high prevalence of male patients,
it was not possible to match 52 patients with appropriate
controls. This did not result in significant differences in
sex or age between the group of 346 patients with HD and
the group of 294 controls.
Functional outcomes in children
The prevalence of constipation was comparable between
children with HD and their controls (22⋅0 versus 14⋅3 per
cent respectively). However, the patients had symptoms
such as straining, incomplete evacuation and anorectal
obstruction significantly more often (Table 2). The patients
also used laxatives (30⋅6 versus 4⋅1 per cent; P< 0⋅001) and
bowel management (17⋅9 versus 0⋅7 per cent; P< 0⋅001)
to treat constipation significantly more frequently than
controls.
The overall prevalence of faecal incontinence was sig-
nificantly higher in children with HD than their controls
(37⋅6 versus 6⋅1 per cent; P< 0⋅001). The most common
subtype of faecal incontinence among the patients was
soiling (34⋅7 per cent), followed by incontinence to liquid
(8⋅7 per cent) and solid (6⋅9 per cent) stool, all of which
were significantly more prevalent than in controls (Table 2).
Bowel management to treat faecal incontinence was used
in 11⋅0 per cent of patients, but only 0⋅7 per cent of
controls (P< 0⋅001).
Functional outcomes in adults
The prevalence of constipation was comparable between
adult patients and adult controls (22⋅0 versus 19⋅0 per
cent; P= 0⋅520). The adults with HD had symptoms such
as straining and incomplete evacuation significantly more
often than their controls (Table 2). Using laxatives was not
more common among patients comparedwith their control
group, whereas they more often used bowel management
to treat constipation (8⋅1 versus 0⋅7 per cent; P= 0⋅002).
The overall prevalence of faecal incontinence was
higher in adult patients compared with their controls (16⋅8
versus 6⋅1 per cent; P= 0⋅003). This was mainly the result
of a significantly higher prevalence of soiling (16⋅8 versus
4⋅1 per cent; P< 0⋅001), which was the only subtype of
faecal incontinence that showed a significant difference
(Table 2).
Comparison of functional outcomes in children
and adult patients
The prevalence of constipation was the same in children
and adults with HD (both 22⋅0 per cent). Nevertheless,
adult patients reported straining and manual manoeuvres
when defaecating more often than children (Table 2). For
the treatment of constipation, children used laxatives (30⋅6
versus 5⋅2 per cent; P< 0⋅001) and bowelmanagement (17⋅9
versus 8⋅1 per cent; P= 0⋅007) significantly more often than
adult patients.
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Table 4 Comparison of functional outcomes and quality of life in patients with Hirschsprung’s disease
Constipation (Rome IV criteria) Faecal incontinence (Rome IV criteria)
No Yes P* No Yes P*
CHQ-CF87 score (n=150)
Behaviour 82 (21–99) 76 (46–97) 0⋅010 83 (61–99) 77 (21–98) 0⋅010
Mental health 81 (50–100) 76 (42–97) 0⋅021 81 (42–100) 77 (50–100) 0⋅056
Self-esteem 77 (30–100) 73 (41–100) 0⋅013 75 (41–100) 77 (30–100) 0⋅877
General health 80 (21–100) 69 (19–99) 0⋅004 81 (19–100) 74 (26–100) 0⋅017
WHOQOL-100 score (n=160)
Overall QoL 16 (10–20) 16 (7–20) 0⋅055 16 (9–20) 16 (7–20) 0⋅319
Physical health 16 (8–20) 15 (7–20) 0⋅077 16 (10–20) 15 (7–20) 0⋅018
Psychological health 16 (10–20) 15 (10–19) 0⋅025 16 (10–20) 15 (10–20) 0⋅204
Social relationships 16 (9–20) 15 (9–19) 0⋅079 16 (9–20) 16 (9–20) 0⋅141
Values are median (range). CHQ-CF87, Child Health Questionnaire Child Form; WHOQOL-100, WHO Quality of Life questionnaire. QoL, quality
of life. *Mann–Whitney U test.
Among patients with HD, the overall prevalence of fae-
cal incontinence was lower in adults than children (16⋅8
versus 37⋅6 per cent; P< 0⋅001). The subtypes of faecal
incontinence, such as soiling, incontinence to solid stool
and incontinence to liquid stool, were all significantly
less prevalent in adults (Table 2). Only 1⋅7 per cent of
the adult patients required bowel management for fae-
cal incontinence, compared with 11⋅0 per cent of children
(P= 0⋅017).
Factors associated with faecal incontinence
In univariable analyses, sex, length of aganglionosis
and postoperative complication were not significantly
associated with faecal incontinence, whereas age group
and redo pull-through procedures were (Table 3). The
multivariable analysis showed that adult patients were
significantly less likely to report faecal incontinence than
children with HD (OR 0⋅35, 95 per cent c.i. 0⋅21 to
0⋅58). Patients who required a redo pull-through were
significantly more likely to have faecal incontinence
than patients who had only undergone one procedure
(OR 3⋅54, 1⋅46 to 8⋅62). There was no significant inter-
action between the variables used in the multivariable
analysis.
Comparison of functional outcomes and quality
of life
The QoL questionnaires were completed by 150 children
and 160 adults withHD; 36 patients omitted theQoLques-
tionnaire after completing the questionnaire on anorectal
functioning.
Comparing mean QoL domain scores of children with
HD with reference data from the general population,
the patients had significantly lower scores for behaviour
(mean(s.d.) 80(13) versus 85(11); P< 0⋅001), self-esteem
(76(13) versus 79(13); P= 0⋅008) and general health (73(20)
versus 82(14); P< 0⋅001) (Fig. 1a). Among children with
HD, the constipated group had significantly lower median
scores on all four domains tested than the group without
constipation (Table 4). Children with faecal incontinence
alone had significantly lowermedian scores for the domains
behaviour (83 (range 61–99) versus 77 (21–98); P= 0⋅010)
and general health (81 (19–100) versus 74 (26–100;
P= 0⋅017) than those without faecal incontinence.
In an analysis of mean QoL domain scores in adult
patients compared with their reference data set, adult
patients had significantly higher scores for overall QoL
(mean(s.d.) 16(3) versus 15(3); P= 0⋅001), physical health
(16(3) versus 15(3); P= 0⋅002), psychological health (16(2)
versus 15(2); P< 0⋅001) and social relationships (16(3) versus
15(3); P= 0⋅002) (Fig. 1b). The only significant difference
between constipated and non-constipated adult patients
was in the domain psychological health (median 16 (range
10–20) versus 15 (10–19); P= 0⋅025). The only significant
difference between faecally continent and incontinent adult
patients was in the domain of physical health (16 (10–20)
versus 15 (7–20); P= 0⋅018).
Discussion
This nationwide study showed that functional outcomes
were better in adults than children withHD, but that defae-
cation disorders persisted in a substantial group of adults.
Patients who required a redo pull-through procedure were
more likely to have faecal incontinence. In the present
cohort, defaecation disorders, especially constipation,
negatively influenced QoL domains, with a more promi-
nent effect in children than adults.
Interestingly, the prevalence of constipation in both chil-
dren and adults with HD was comparable to that in their
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respective control groups. These findings warrant reflec-
tion. The true prevalence of constipation in patients with
HD may be masked by the more frequent use of laxatives
and bowel management than in controls. If true, this could
also mean that the prevalence of constipation may decrease
as the patients grow older, because the use of laxatives and
rectal irrigation was significantly lower in adults than in
children. As indicated by the increased frequency of symp-
toms found in this study, it may be that both children and
adults with HD experienced more severe forms of consti-
pation than controls.
In contrast to constipation, the prevalence of faecal
incontinence was significantly higher in patients with HD
than controls. It is important to note, however, that chil-
drenmore often had severe subtypes of faecal incontinence,
such as incontinence to solid and liquid stool, whereas
adult patients often reported soiling only. This means that
both the prevalence and severity of faecal incontinencemay
decrease with age, although adults with HD did retain a
significantly higher prevalence of soiling than controls. In
contrast to the present results, a recent study6 concluded
that faecal incontinence would eventually diminish to a
prevalence not significantly different from that of healthy
controls, even though soiling persisted in well over 40
per cent in their adult subgroup. It therefore seems that
faecal continence may improve with age, but that prob-
lems persist well into adulthood. There are various reasons
for this. Faecal incontinence in these patients may result
from damage to the anal sphincter during reconstructive
surgery25, depending on the type and quality of the initial
surgery. With regard to the type of surgery, there is cur-
rently little evidence that substantiates the decision to opt
for one technique over another26–28. The authors believe
that further analyses, such as anorectal manometry or anal
sphincter electromyography, should be performed to assess
the differences between the techniques, especially between
the transanal endorectal pull-through and Duhamel oper-
ations, which currently are the two most commonly per-
formed procedures. Such investigations might also give
an objective prognosis regarding the functional outcomes
in individual patients. In addition, impaired continence
may result from more severe constipation in patients with
HD21, which could be the result of a persistently absent
rectoanal inhibitory reflex, stenosis of the anal sphincter
following surgery or lack of pelvic floor coordination29.
The absence of a rectal reservoir following surgery and sub-
sequent increased defaecation frequency may further con-
tribute to impaired faecal continence. In the present study,
patients who required a redo pull-through procedure were
significantly more likely have faecal incontinence. A recent
study30 indeed showed that short-term outcomes after redo
pull-through procedures were complicated by a relatively
high rate of soiling and faecal incontinence30. Important
to note, however, is the finding that other functional symp-
toms, such as constipation and abdominal pain, improved
following the redo procedure30. It remains unclear to what
extent the redo procedure itself contributed to the impaired
faecal continence, because it may already have been worse
in these patients before the redo procedure. The authors
merely conclude that a redo procedure may ultimately
be necessary in some patients, but that one should be
cautious about promising favourable functional outcomes,
because the prevalence of faecal incontinence remains high
after redo procedures. Given the heterogeneity of surgical
techniques used, more comprehensive studies are required
to analyse accurately the possible association between
long-term outcomes and different types of pull-through
procedure.
In terms of QoL, the present results showed that children
with HD had significantly lower QoL domain scores com-
pared with the reference data. These differences may be
explained partially by poor functional outcomes, because
constipation and faecal incontinence negatively influenced
severalQoLdomains. In contrast to children, adult patients
scored better on all four domains tested compared with
their respective reference data sets. This could be the result
of improved functional outcomes in adult patients com-
pared with children. A more plausible explanation might
be that adults develop better coping strategies to deal with
their complaints31,32. By way of illustration, adults may
have more options to adapt their lives to accommodate
for any defaecation disorders, whereas children are often
bound by fixed schedules, such as school and after-school
activities.
The strength of this study was the large number of par-
ticipants, from all six paediatric surgery centres in the
Netherlands, and the relatively high response rate of 55⋅9
per cent. One limitation was the significant age differ-
ence between included patients and non-respondents, even
though the remaining variables all proved to be stat-
istically non-significant. The difference in age between
respondents and non-respondents was most likely the
result of the high response rate among children with HD,
supported by their parents, who were found to be more
motivated to participate than adult patients. An attempt
was made to overcome this possible inclusion bias by per-
forming separate analyses in adults and children, and mak-
ing age- and sex-matched comparisons. Another limitation
may be the cross-sectional design of this study. A longi-
tudinal design would have been preferable to analyse the
influence of ageing on functional outcomes.
© 2019 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2019; 106: 499–507
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The results of this nationwide study showed that func-
tional outcomes were better in adults than children with
HD, although symptoms of constipation and soiling per-
sisted in a substantial group of adults. One factor associated
with poor functional outcomes was a redo pull-through
procedure, following which patients were significantly
more likely have faecal incontinence. Poor functional out-
comes negatively influenced QoL in children, whereas this
influence diminished partially upon reaching adulthood,
indicating better coping strategies in adults. Persistent
symptoms of constipation and soiling indicate the need
for counselling and transitional care in a specific group of
patients.
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